Antibody Response to Omicron and Other Virus Variants Effectively Replenished after 3rd and 4th COVID-19 Vaccination

Researchers from the Paul-Ehrlich-Institut (PEI) and the Main-Kinzig Clinics investigated the antibody response against various SARS-CoV-2 virus variants over time following COVID-19 mRNA (Comirnaty) vaccinations. After double vaccination against COVID-19, antibody levels against the Omicron variant are low. Omicron is currently the dominant variant in Germany. mRNA booster vaccinations significantly increase antibody levels against Omicron. Vaccines reports on the results.

Quelle: IDW Informationsdienst Wissenschaft